BGI, Imperial College, Waters Ink Deal to Accelerate Translational Medicine | GenomeWeb

NEW YORK (GenomeWeb) – BGI, Imperial College of London, and Waters today signed a framework agreement to accelerate translational medicine.

Through R&D projects incorporating omics-related and clinical applications, the partners plan to develop comprehensive standards and approaches for human omics testing and data analysis, BGI said. Work will focus on biomarker detection, as well as the integration of multidimensional data and information from 3D imaging, for example, in order to translate, accumulate, and update omics, clinical, and health knowledge.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.